Apr 7, 2021 4:05 pm EDT NeoGenomics Schedules its First Quarter 2021 Earnings Release for May 5, 2021
Mar 16, 2021 7:00 am EDT NeoGenomics and Elevation Oncology Announce Collaboration to Expand Genomic Testing for NRG1 Fusions Across Solid Tumors in Support of the Phase 2 CRESTONE Study
Mar 1, 2021 7:00 am EST NeoGenomics To Participate In The Virtual Raymond James 42nd Annual Institutional Investors Conference
Feb 25, 2021 7:00 am EST NeoGenomics To Participate In The Virtual 10th Annual SVB Leerink Global Healthcare Conference
Feb 24, 2021 7:01 am EST NeoGenomics Reports 18% Revenue Growth to $126 Million in the Fourth Quarter
Feb 16, 2021 7:00 am EST NeoGenomics to Participate in the BTIG Virtual Medtech, Digital Health, Life Science & Diagnostic Tools Conference
Feb 5, 2021 7:00 am EST NeoGenomics Schedules its Fourth Quarter and Full Year 2020 Earnings Release for February 24, 2021
Feb 4, 2021 7:00 am EST Parexel and NeoGenomics Announce Strategic Collaboration in Precision Medicine to Improve Study Designs and Accelerate Patient Matching in Oncology Clinical Trials
